A Study to Learn About The COVID-19 (Study) Vaccine (Called COMIRNATY) in People That Are Less Than 21 Years Old.

A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 319 participants.

Also called NCT05295290

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose other
Phase
Phase 4
Enrolled
  • 319 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05295290
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05295290. Non-randomized; no masking; primary purpose other. Start 2022-11-21 (actual); primary completion 2029-04-02 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study to Learn About The COVID-19 (Study) Vaccine (Called COMIRNATY) in People That Are Less Than 21 Years Old.
Condition
Myocarditis
Intervention (Diagnostic test)
Cardiac Imaging
Lead sponsor
Pfizer (class: industry)
Collaborator
Carelon Research (class: other)
Collaborator
National Heart, Lung, and Blood Institute (NHLBI) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct05295290
Content hash
fb4a2518cd7d01ef35cb20aa3068fcf15011c6bd17db5cc8086dad6633896286